Amitav Pharma announced it has purchased all the patent rights on the Ibuprofen brand from Amags Pharmacia Inc. for $2.7 billion, with a $2 million option to buy all the remaining patents for the drug from Amagi, which acquired the rights in October 2016.Amagi will be Amag’s exclusive international drug development company and will continue […]

Continue Reading...